有關 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任 何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 GoFintech Quantum Innovation Limited 國富量子創新有限公司 （前稱 GoFintech Innovation Limited 國富創新有限公司） （於開曼群島註冊成立之有限公司） 網址：https://290.com.hk （股份代號：290） 自願性公告 與金涌投資有限公司之戰略合作 之補充公告 茲提述國富量子創新有限公司（「本公司」）日期為二零二五年八月二十六日有關（其 中包括）戰略合作之自願性公告（「該公告」）。除另有界定外，本公告所用詞彙與 該公告所界定者具有相同涵義。 本公司謹此向本公司股東及潛在投資者提供有關戰略合作之補充資料。 戰略合作 — RWA代幣化產品及RWA項目 鑒於本公司與金涌投資簽署之戰略合作備忘錄僅構成合作之指示性框架，擬開展 之RWA 代幣化產品及RWA 項目目前仍在考量及評估中。於本公告日期，該等產品 及項目可能包括符合以下條件的 ...

Core Viewpoint - Huajian Medical (01931) is acquiring approximately 1.848 billion shares of Guofu Quantum, representing 20.31% of its total issued share capital, for about HKD 3.142 billion, positioning Huajian Medical as the largest single shareholder of Guofu Quantum [1] Group 1 - The acquisition is a key move for Huajian Medical to advance its strategy of establishing a Real World Asset (RWA) tokenization exchange [1] - Huajian Medical possesses extensive resources in the medical industry, while its exchange offers a technology platform and trading venue for asset tokenization [1] - Guofu Quantum has strong capabilities in financial technology, providing financial licensing resources, digital asset issuance and trading capabilities, as well as expertise in quantum technology [1] Group 2 - Huajian Medical can leverage Guofu Quantum's 22.5% stake in Southern Dongying to collaboratively build a blockchain and financial technology-centric on-chain financial ecosystem [1] - This platform aims to integrate compliant digital architecture with traditional asset forms, promoting asset tokenization, fragmentation, and cross-border flow [1] - The initiative is focused on creating a new type of financial infrastructure [1]

Core Viewpoint - Huajian Medical (01931) plans to acquire approximately 1.848 billion shares of Guofu Quantum, representing 20.31% of its total issued share capital, for about HKD 3.142 billion, making Huajian the largest single shareholder of Guofu Quantum after the transaction [1] Group 1: Acquisition Details - The acquisition price for Guofu Quantum shares is approximately HKD 3.142 billion [1] - After the acquisition, Huajian Medical will hold 20.31% of Guofu Quantum's total issued share capital [1] Group 2: Strategic Importance - This acquisition is a key move for Huajian Medical to advance its strategy of establishing a Real World Asset (RWA) tokenization exchange [1] - Huajian Medical possesses extensive resources in the medical industry, while Guofu Quantum has strong capabilities in financial technology [1] Group 3: Resource Sharing and Synergy - Huajian Medical can leverage Guofu Quantum's 22.5% stake in Southern Dongying to collaboratively build a blockchain and financial technology-centric on-chain financial ecosystem [1] - The new platform aims to integrate compliant digital architecture with traditional asset forms, promoting asset tokenization, fragmentation, and cross-border flow [1]

Core Viewpoint - The company has terminated the original subscription agreement due to unmet conditions and current market conditions, and has entered into a new subscription agreement with 11 subscribers to issue 745 million shares at a discounted price [1] Group 1: Subscription Agreement Details - The original subscription agreement will no longer proceed, and both parties will not seek compensation from each other [1] - A new subscription agreement was signed on September 4, 2025, for a total of 745 million shares, representing approximately 7.57% of the enlarged total share capital [1] - The subscription price is set at HKD 1.78 per share, which is about 16.43% lower than the closing price of HKD 2.13 on September 4 [1] Group 2: Financial Implications - The new subscription is expected to raise approximately HKD 1.3264 billion in total funds, with a net amount of about HKD 1.3214 billion [1]

Group 1 - The core point of the announcement is that the company, Yingyu Universe, has entered into a subscription agreement with Guofu Quantum to issue approximately 169 million shares at a subscription price of HKD 1.78 per share, which represents a discount of about 16.43% compared to Guofu Quantum's closing price of HKD 2.13 on the date of the agreement [1][2] - Upon completion of the agreement, the company will hold approximately 169 million shares of Guofu Quantum, which will represent about 1.85% of the total issued shares as of the announcement date and approximately 1.71% of the expanded total issued shares after the subscription [1] - The company views this subscription as a favorable investment opportunity in Guofu Quantum, given the recent market price of its shares [2] Group 2 - Guofu Quantum is recognized as a prominent fintech investment platform in Hong Kong, supported by the Greater Bay Area, and has a strong reputation in cross-border and cross-industry operations, focusing on international markets [2] - Guofu Quantum and its subsidiaries maintain a significant position in the financial services industry in the local Hong Kong market and are aligned with the Hong Kong government's policies to promote digital economic development through strategic investments in fintech [2] - By focusing on technological innovation, Guofu Quantum not only drives its own development but also strengthens Hong Kong's status as a global financial center and contributes to the acceleration of the Web 3.0 ecosystem [2]

Core Viewpoint - The company, Yingyu Universe, has entered into a subscription agreement with Guofu Quantum, agreeing to issue a total of 168,539,325 subscription shares at a price of HKD 1.78 per share, which is seen as a favorable investment opportunity given the recent market price of Guofu Quantum's shares [1] Company Summary - Guofu Quantum is a well-known financial technology investment platform in Hong Kong, supported by the Greater Bay Area, with a strong reputation in cross-border and cross-industry operations [1] - The company and its subsidiaries maintain a significant position in the financial services industry within the local market [1] - Guofu Quantum is strategically investing in the fintech sector, aligning with the Hong Kong government's initiatives to promote digital economic development [1] Industry Summary - The focus on technological innovation by Guofu Quantum not only drives its own development but also reinforces Hong Kong's status as a global financial center [1] - The company's efforts contribute to accelerating the construction of the Web 3.0 ecosystem [1]

Group 1 - The original subscription agreement has become invalid as the conditions were not met, and the company will not proceed with the original subscription matters [1] - The company and 11 subscribers have entered into 11 independent subscription agreements, conditionally agreeing to issue a total of 745 million subscription shares, representing approximately 7.57% of the enlarged issued share capital [1] - The subscription price is set at HKD 1.78 per share, which is a discount of approximately 16.43% compared to the closing price of HKD 2.13 on September 4 [1] Group 2 - The total amount raised from the subscription is approximately HKD 1.3264 billion, with a net amount of approximately HKD 1.3214 billion [1]

格隆汇9月4日丨国富量子(00290.HK)公告，董事会宣布，(i)经虑及原认购协议最后截止日期为2025年9 月4日且原认购协议项下的先决条件并未达成；及(ii)鉴于目前市况，公司与各认购人已就原认购事项进 行公平磋商，并同意不再根据原认购协议进行原认购事项。因此，原认购协议已失效而原认购事项将不 会进行。任何一方概不会就原认购协议向另一方提出任何索偿。 新订根据一般授权认购新股份。于2025年9月4日，公司与十一(11)名认购人订立十一(11)份独立认购协 议，据此，公司有条件同意向认购人配发及发行，而认购人有条件同意认购合共745,168,534股认购股 份，认购价为每股认购股份1.78港元。认购价每股认购股份1.78港元较股份于2025年9月4日(即认购协议 日期)在联交所所报收市价每股2.13港元折让约16.43%；透过认购事项筹集所得款项总额及所得款项净 额(经扣除认购事项相关成本及开支后)将分别约为13.26亿港元及13.2亿港元。按此基准，认购股份认购 净价将为每股认购股份约1.77港元。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任 何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 網址：https://290.com.hk （股份代號：290） 原訂根據一般授權認購新股份失效 及 新訂根據一般授權認購新股份 本公告僅供參考，並不構成收購、購買或認購本公司任何證券之邀請或要約。 本公告不會直接或間接於或向美國（包括美國的領土及屬地、任何州以及哥倫比 亞特區）派發。本公告並不構成或組成在美國境內購買或認購證券的任何要約或 招攬的一部分。本公告所述認購股份並無亦不會根據一九三三年美國證券法（「證 券法」）登記。 認購股份不得在美國境內或向美籍人士（定義見證券法S規例）或以其名義或為其 利益提呈發售或出售，惟獲豁免遵守證券法登記規定者除外。證券將不會於美國 公開發售。 GoFintech Quantum Innovation Limited 國富量子創新有限公司 （前稱 GoFintech Innovation Limited 國富創新有限公司） （於開曼群島註冊成立之有限公司） 由於認 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 國富量子創新有限公司（於開曼群島註冊成立之有限公司） 呈交日期: 2025年9月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00290 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 20,000,000,000 | HKD | | 0.1 HKD | | 2,000,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 20,000,000,000 | HKD | | 0.1 HKD | | 2,000,000,000 | ...